| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $53.4M | -18.5% |
| Cost of Revenue | $24.3M | +5.8% |
| R&D Expense | $13.0M | -24.1% |
| SG&A Expense | $12.2M | -18.5% |
| Operating Income | $3.9M | -62.6% |
| Pre-tax Income | $4.2M | -51.5% |
| Income Tax | $1.2M | +381.1% |
| Net Income | $2.9M | -64.7% |
| EPS (Basic) | $0.04 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.8M | -16.4% |
| Accounts Receivable | $2.9M | -44.8% |
| Inventory | $21.2M | +11.5% |
| Current Assets | $60.1M | -14.1% |
| Total Assets | $73.4M | -13.0% |
| Current Liabilities | $25.6M | -43.7% |
| Total Liabilities | $30.2M | -40.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $8.7M | +758.1% |
| Capital Expenditures | $1.3M | +11.6% |
| Investing Cash Flow | $4.2M | +125.3% |
| Financing Cash Flow | -$16.8M | -168.1% |
| Free Cash Flow | $7.4M | +399.6% |
| -66.7% |
| EPS (Diluted) | $0.04 | -55.6% |
| Stockholders' Equity |
| $43.2M |
| +28.7% |